Haoxiangni Health Food Co.,Ltd.
SZSE:002582.SZ
7.47 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 1,728.222 | 1,400.491 | 1,281.123 | 3,001.376 | 5,961.168 | 4,949.437 | 4,070.45 | 2,071.832 | 1,113.05 | 972.924 | 908.038 | 896.547 | 784.77 | 657.055 | 408.093 | 282.115 |
Cost of Revenue
| 1,283.444 | 1,081.255 | 947.057 | 2,244.161 | 4,314.867 | 3,540.04 | 2,888.197 | 1,373.041 | 666.552 | 550.567 | 561.237 | 610.157 | 571.002 | 482.382 | 309.919 | 215.298 |
Gross Profit
| 444.778 | 319.235 | 334.066 | 757.214 | 1,646.301 | 1,409.397 | 1,182.253 | 698.791 | 446.498 | 422.357 | 346.801 | 286.391 | 213.768 | 174.673 | 98.175 | 66.817 |
Gross Profit Ratio
| 0.257 | 0.228 | 0.261 | 0.252 | 0.276 | 0.285 | 0.29 | 0.337 | 0.401 | 0.434 | 0.382 | 0.319 | 0.272 | 0.266 | 0.241 | 0.237 |
Reseach & Development Expenses
| 28.572 | 38.651 | 34.188 | 33.997 | 35.388 | 30.061 | 23.348 | 18.382 | 22.218 | 17.117 | 25.062 | 26.014 | 8.473 | 0 | 0 | 0 |
General & Administrative Expenses
| 48.654 | 33.778 | 42.326 | 38.417 | 39.27 | 43.424 | 41.665 | 31.959 | 26.592 | 22.839 | 25.697 | 19.155 | 15.022 | 38.843 | 21.27 | 10.756 |
Selling & Marketing Expenses
| 364.157 | 315.559 | 242.194 | 736.561 | 1,279.013 | 1,020.159 | 860.851 | 543.34 | 344.462 | 261.191 | 171.026 | 106.158 | 53.777 | 28.187 | 16.81 | 15.788 |
SG&A
| 412.811 | 349.338 | 284.52 | 774.978 | 1,318.283 | 1,063.583 | 902.516 | 575.299 | 371.054 | 284.03 | 196.723 | 125.313 | 68.799 | 67.03 | 38.08 | 26.544 |
Other Expenses
| -1.048 | 72.849 | 61.87 | 67.543 | 101.558 | -4.888 | -2.072 | 70.377 | 11.296 | 10.303 | 8.154 | 10.111 | 22.933 | 10.802 | 6.557 | 7.87 |
Operating Expenses
| 515.521 | 460.837 | 380.578 | 876.518 | 1,455.229 | 1,212.764 | 1,051.139 | 698.629 | 457.21 | 355.789 | 267.991 | 193.883 | 107.759 | 68.698 | 39.079 | 27.353 |
Operating Income
| -49.731 | -90.356 | 17.722 | 2,950.63 | 246.564 | 157.791 | 126.391 | -11.952 | -16.999 | 52.103 | 111.314 | 94.48 | 98.728 | 90.357 | 52.018 | 33.547 |
Operating Income Ratio
| -0.029 | -0.065 | 0.014 | 0.983 | 0.041 | 0.032 | 0.031 | -0.006 | -0.015 | 0.054 | 0.123 | 0.105 | 0.126 | 0.138 | 0.127 | 0.119 |
Total Other Income Expenses Net
| -1.048 | -143.813 | 48.957 | -38.937 | -7.283 | -43.73 | -6.794 | 56.85 | 4.927 | -4.215 | 40.018 | 11.723 | 15.652 | -4.817 | -0.521 | 1.707 |
Income Before Tax
| -50.78 | -234.169 | 66.68 | 2,911.693 | 239.281 | 152.903 | 124.319 | 57.012 | -5.786 | 62.353 | 118.827 | 104.231 | 121.661 | 101.159 | 58.574 | 41.171 |
Income Before Tax Ratio
| -0.029 | -0.167 | 0.052 | 0.97 | 0.04 | 0.031 | 0.031 | 0.028 | -0.005 | 0.064 | 0.131 | 0.116 | 0.155 | 0.154 | 0.144 | 0.146 |
Income Tax Expense
| 5.757 | -31.014 | 11.75 | 763.607 | 48.193 | 43.912 | 26.953 | 17.921 | -2.552 | 8.652 | 16.8 | 3.803 | 9.148 | 7.031 | 7.103 | 3.889 |
Net Income
| -51.892 | -203.155 | 61.634 | 2,155.054 | 192.623 | 129.572 | 106.896 | 39.272 | -3.233 | 53.701 | 102.028 | 100.428 | 112.513 | 94.128 | 51.488 | 37.282 |
Net Income Ratio
| -0.03 | -0.145 | 0.048 | 0.718 | 0.032 | 0.026 | 0.026 | 0.019 | -0.003 | 0.055 | 0.112 | 0.112 | 0.143 | 0.143 | 0.126 | 0.132 |
EPS
| -0.12 | -0.46 | 0.13 | 4.31 | 0.38 | 0.25 | 0.21 | 0.11 | -0.01 | 0.18 | 0.35 | 0.34 | 0.43 | 0.43 | 0.23 | 0.4 |
EPS Diluted
| -0.12 | -0.46 | 0.13 | 4.31 | 0.38 | 0.25 | 0.21 | 0.11 | -0.01 | 0.18 | 0.35 | 0.34 | 0.43 | 0.43 | 0.23 | 0.4 |
EBITDA
| 82.025 | 58.684 | 151.383 | 3,133.455 | 429.241 | 346.049 | 275.798 | 195.287 | 82.702 | 136.024 | 166.528 | 140.181 | 157.727 | 122 | 67.652 | 44.798 |
EBITDA Ratio
| 0.047 | 0.042 | 0.118 | 1.044 | 0.072 | 0.07 | 0.068 | 0.094 | 0.074 | 0.14 | 0.183 | 0.156 | 0.201 | 0.186 | 0.166 | 0.159 |